SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far
暂无分享,去创建一个
Amjad D. Al-Nasser | Mazhar S Al Zoubi | Firas A Rabi | Ghena A Kasasbeh | Dunia M Salameh | Amjad D Al-Nasser | M. A. Al Zoubi
[1] Yi Fan,et al. Bat Coronaviruses in China , 2019, Viruses.
[2] W. Liang,et al. Clinical characteristics of 2019 novel coronavirus infection in China , 2020, medRxiv.
[3] J. Christie,et al. Acute Respiratory Distress Syndrome Phenotypes , 2019, Seminars in Respiratory and Critical Care Medicine.
[4] N. Seidah,et al. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread , 2005, Virology Journal.
[5] S. Lindstrom,et al. First Case of 2019 Novel Coronavirus in the United States , 2020, The New England journal of medicine.
[6] M. Lipsitch,et al. Defining the Epidemiology of Covid-19 - Studies Needed. , 2020, The New England journal of medicine.
[7] Christian Drosten,et al. Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group , 2020, bioRxiv.
[8] G. Acsadi,et al. Direct gene transfer into mouse muscle in vivo. , 1990, Science.
[9] A. Aguilar-Shea,et al. [COVID-19 and the hope for immunity]. , 2020, Atencion primaria.
[10] J. Utikal,et al. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer , 2017, Nature.
[11] M. Arbabi-Ghahroudi. Camelid Single-Domain Antibodies: Historical Perspective and Future Outlook , 2017, Front. Immunol..
[12] Y. Guan,et al. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings , 2004, Thorax.
[13] Yichong Li,et al. Prevalence and patterns of tobacco smoking among Chinese adult men and women: findings of the 2010 national smoking survey , 2016, Journal of Epidemiology & Community Health.
[14] Novel Coronavirus Pneumonia Emergency Response Epidemiol Team. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. , 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.
[15] A. Dömling,et al. Chemistry and Biology of SARS-CoV-2 , 2020, Chem.
[16] Mark Chappell,et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury , 2005, Nature Medicine.
[17] R. Colwell,et al. Human Coronavirus 229E Remains Infectious on Common Touch Surface Materials , 2015, mBio.
[18] Christian Drosten,et al. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells , 2020, bioRxiv.
[19] Manar Mohammed El Tabaa,et al. Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost. , 2020 .
[20] P. Hart,et al. A phase 1/2 trial to evaluate the pharmacokinetics, safety, and efficacy of NI-03 in patients with chronic pancreatitis: study protocol for a randomized controlled trial on the assessment of camostat treatment in chronic pancreatitis (TACTIC) , 2019, Trials.
[21] Elizabeth L. Beam,et al. The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] R. Wax,et al. Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients , 2020, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.
[23] I. Astuti,et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.
[24] Christian Drosten,et al. Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response , 2011, Journal of Virology.
[25] J. A. Comer,et al. A novel coronavirus associated with severe acute respiratory syndrome. , 2003, The New England journal of medicine.
[26] A. Maxmen. More than 80 clinical trials launch to test coronavirus treatments , 2020, Nature.
[27] D. Burton,et al. Passive immunotherapy of viral infections: 'super-antibodies' enter the fray , 2018, Nature Reviews Immunology.
[28] Zhènglì Shí,et al. Origin and evolution of pathogenic coronaviruses , 2018, Nature Reviews Microbiology.
[29] Giorgio Guzzetta,et al. The natural history of varicella zoster virus infection in Norway: Further insights on exogenous boosting and progressive immunity to herpes zoster , 2017, PloS one.
[30] Jincun Zhao,et al. A Transmembrane Serine Protease Is Linked to the Severe Acute Respiratory Syndrome Coronavirus Receptor and Activates Virus Entry , 2010, Journal of Virology.
[31] Hongzhou Lu,et al. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle , 2020, Journal of medical virology.
[32] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[33] Jing Zhao,et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.
[34] Özlem Türeci,et al. mRNA-based therapeutics — developing a new class of drugs , 2014, Nature Reviews Drug Discovery.
[35] W. Zuo,et al. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov , 2020, bioRxiv.
[36] Wu Zhong,et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro , 2020, Cell Research.
[37] Michael Proschan,et al. A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics. , 2019, The New England journal of medicine.
[38] Wenhui Li,et al. A 193-Amino Acid Fragment of the SARS Coronavirus S Protein Efficiently Binds Angiotensin-converting Enzyme 2* , 2004, Journal of Biological Chemistry.
[39] P. Daszak,et al. Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin , 2018, Nature.
[40] K. Shadan,et al. Available online: , 2012 .
[41] E. Holmes,et al. The proximal origin of SARS-CoV-2 , 2020, Nature Medicine.
[42] S. Mulangu. 843. The PALM Consortium: A Multicenter, Multioutbreak Randomized Controlled Trial of Ebola Virus Disease Therapeutics , 2019, Open Forum Infectious Diseases.
[43] Natasha S Crowcroft,et al. The basic reproduction number (R0) of measles: a systematic review. , 2017, The Lancet. Infectious diseases.
[44] Jingping Yuan,et al. Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China. , 2020, JAMA.
[45] David C. Yeo,et al. Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays , 2020, Journal of Clinical Virology.
[46] Akram Khan,et al. A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome , 2017, Critical Care.
[47] Don Klinkenberg,et al. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[48] G. Gao,et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.
[49] Timothy F. Leslie,et al. Complexity of the Basic Reproduction Number (R0) , 2019, Emerging infectious diseases.
[50] Fei Deng,et al. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin , 2020, bioRxiv.
[51] Lisa E. Gralinski,et al. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses , 2017, Science Translational Medicine.
[52] D. Atanackovic,et al. A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer , 2019, Cancer Immunology, Immunotherapy.
[53] O. Jahn,et al. TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein , 2013, Journal of Virology.
[54] Arthur S Slutsky,et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure , 2005, Nature.
[55] A. Al-Tammemi,et al. The Battle Against COVID-19 in Jordan: An Early Overview of the Jordanian Experience , 2020, Frontiers in Public Health.
[56] B. Prabhakar,et al. Human Monoclonal Antibodies against Highly Conserved HR1 and HR2 Domains of the SARS-CoV Spike Protein Are More Broadly Neutralizing , 2012, PloS one.
[57] Yan Bai,et al. Presumed Asymptomatic Carrier Transmission of COVID-19. , 2020, JAMA.
[58] L. Yang,et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak , 2020, International Journal of Infectious Diseases.
[59] Ting Yu,et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.
[60] B. Graham,et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation , 2020, Science.
[61] Koichi Yuki,et al. COVID-19 pathophysiology: A review , 2020, Clinical Immunology.
[62] A. Gurung,et al. Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 Mpro enzyme through in silico approach , 2020, Life Sciences.
[63] U. Şahin,et al. mRNA: A Versatile Molecule for Cancer Vaccines. , 2017, Current issues in molecular biology.
[64] William B. Karesh,et al. Stability of Middle East Respiratory Syndrome Coronavirus in Milk , 2014, Emerging infectious diseases.
[65] D. Cyranoski. Did pangolins spread the China coronavirus to people? , 2020 .
[66] Yanchen Zhou,et al. Protease inhibitors targeting coronavirus and filovirus entry , 2015, Antiviral Research.
[67] Jens H. Kuhn,et al. Retroviruses Pseudotyped with the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Efficiently Infect Cells Expressing Angiotensin-Converting Enzyme 2 , 2004, Journal of Virology.
[68] Min Kang,et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients , 2020, The New England journal of medicine.
[69] China Cdc Weekly. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020 , 2020, China CDC weekly.
[70] G. Gao,et al. A Novel Coronavirus Genome Identified in a Cluster of Pneumonia Cases — Wuhan, China 2019−2020 , 2020, China CDC weekly.
[71] K. Iwakiri,et al. Camostat Mesilate, Pancrelipase, and Rabeprazole Combination Therapy Improves Epigastric Pain in Early Chronic Pancreatitis and Functional Dyspepsia with Pancreatic Enzyme Abnormalities , 2018, Digestion.
[72] G. Kampf,et al. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents , 2020, Journal of Hospital Infection.
[73] Kai Zhao,et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.
[74] G. Cai. Tobacco-Use Disparity in Gene Expression of ACE2, the Receptor of 2019-nCov , 2020 .
[75] P. Vollmar,et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany , 2020, The New England journal of medicine.